Hepatitis c and hepatitis b seroprevalence and associated risk factors in hemodialysis patients in guilan province, north of iran

Hepatitis Monthly

Volumn 11, Issue 3, 2011, Pages 178-181

  Joukar, Farahnaz ^a   Besharati, Sepiedeh ^a   Mirpour, Hasan ^a   Mansour Ghanaei, Fariborz ^a  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis b hepatitis c hemodialysis

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEMODIALYSIS; HEPATITIS B; HEPATITIS C; HUMAN; INFECTION RISK; IRAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RISK FACTOR; SEROPREVALENCE; SEX DIFFERENCE; TREATMENT DURATION;

EID: 79955598469     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology. 2002; 36(1):3-10.
2. Fabrizi F, Lunghi G, Ganeshan SV, Martin P, Messa P. Hepatitis C virus infection and the dialysis patient. Semin Dial. 2007; 20(5):416-22.
3. Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004; 65(6):2335-42.
4. Sulowicz W, Radziszewski A, Chowaniec E. Hepatitis C virus infection in dialysis patients. Hemodial Int. 2007; 11(3):286-95.
5. Lu SN, Tung HD, Chen TM, Lee CM, Wang JH, Hung CH, et al. Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion? J Viral Hepat. 2004; 11(6):563-70.
6. Fabrizi F, Takkouche B, Lunghi G, Dixit V, Messa P, Martin P. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J Viral Hepat. 2007; 14(10):697-703.
7. Butt AA, Skanderson M, McGinnis KA, Ahuja T, Bryce CL, Barnato AE, et al. Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis. J Viral Hepat. 2007; 14(10):688-96.
8. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G. Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis. Aliment Pharmacol Ther. 2004; 20(11-12):1271-7.
9. Henderson WA, Shankar R, Gill JM, Kim KH, Ghany MG, Skanderson M, et al. Hepatitis C progressing to hepatocellular carcinoma: the HCV dialysis patient in dilemma. J Viral Hepat. 2010; 17(1):59-64.
10. Nicolardi E, Grieco A, Rapaccini GL, Pompili M. [Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients]. G Ital Nefrol. 2010; 27(3):262-73.
11. Tu AW, Buxton JA, Whitlock M, Djurdjev O, Chong M, Krajden M, et al. Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia: Follow-up after a possible breach in hemodialysis machines. Can J Infect Dis Med Microbiol. 2009; 20(2):e19-23.
12. Sun J, Yu R, Zhu B, Wu J, Larsen S, Zhao W. Hepatitis C infection and related factors in hemodialysis patients in china: systematic review and meta-analysis. Ren Fail. 2009; 31(7):610-20.
13. Natov SN, Pereira BJ. Hepatitis C virus in chronic dialysis patients. Minerva Urol Nefrol. 2005; 57(3):175-97.
14. Telaku S, Fejza H, Elezi Y, Bicaj T. Hepatitis B and C in dialysis units in Kosova. Virol J. 2009; 6:72.
15. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, et al. Asian- Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int. 2008; 2(3):263-83.
16. Gane EJ. The Roadmap concept: using early on-treatment virologic responses to optimize long-term outcomes for patients with chronic hepatitis B. Hepatol Int. 2008; 2(3):304-7.
17. Al Hijazat M, Ajlouni YM. Hepatitis B infection among patients receiving chronic hemodialysis at the Royal Medical Services in Jordan. Saudi J Kidney Dis Transpl. 2008; 19(2):260-7.
18. Petrosillo N, Gilli P, Serraino D, Dentico P, Mele A, Ragni P, et al. Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis. 2001; 37(5):1004-10.
19. Broumand B, Shamshirsaz AA, Kamgar M, Hashemi R, Aiazi F, Bekheirnia M, et al. Prevalence of hepatitis C infection and its risk factors in hemodialysis patients in tehran: preliminary report from the effect of dialysis unit isolation on the incidence of hepatitis C in dialysis patients project. Saudi J Kidney Dis Transpl. 2002; 13(4):467-72.
20. Nemati E, Alavian SM, Taheri S, Moradi M, Pourfarziani V, Einollahi B. Hepatitis C virus infection among patients on hemodialysis: a report from a single center in Iran. Saudi J Kidney Dis Transpl. 2009; 20(1):147-53.
21. Espinosa M, Martin-Malo A, Alvarez de Lara MA, Gonzalez R, Rodriguez M, Aljama P. Natural history of acute HCV infection in hemodialysis patients. Clin Nephrol. 2002; 58(2):143-50.
22. Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S. Hepatitis B and C in dialysis units in Iran: changing the epidemiology. Hemodial Int. 2008; 12(3):378-82.
23. Assarehzadegan MA, Shakerinejad G, Noroozkohnejad R, Amini A, Rahim Rezaee SA. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran. Saudi J Kidney Dis Transpl. 2009; 20(4):681-4.
24. Boulaajaj K, Elomari Y, Elmaliki B, Madkouri B, Zaid D, Benchemsi N. [Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca]. Nephrol Ther. 2005; 1(5):274-84.
25. Olut AI, Ozsakarya F, Dilek M. Seroprevalence of hepatitis C virus infection and evaluation of serum aminotransferase levels among haemodialysis patients in Izmir, Turkey. J Int Med Res. 2005; 33(6):641-6.
26. Silva LK, Silva MB, Rodart IF, Lopes GB, Costa FQ, Melo ME, et al. Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil. Braz J Med Biol Res. 2006; 39(5):595-602.
27. Mansour-Ghanaei F, Sadeghi A, Mashhour M, Joukar F, Besharati S, Roshan Z, et al. Prevalence of Hepatitis B and C Infection in Hemodialysis Patients of Rasht (Center of Guilan Province, Northern Part of Iran). Hepat Mon. 2009; 9(1):45-9.
28. Taziki O, Espahbodi F. Prevalence of hepatitis C virus infection in hemodialysis patients. Saudi J Kidney Dis Transpl. 2008; 19(3):475-8.
29. Ocak S, Duran N, Kaya H, Emir I. Seroprevalence of hepatitis C in patients with type 2 diabetes mellitus and non-diabetic on haemodialysis. Int J Clin Pract. 2006; 60(6):670-4.
30. Hussein MM, Mooij JM, Hegazy MS, Bamaga MS. The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit. Saudi J Kidney Dis Transpl. 2007; 18(1):107-13.
31. Dattolo P, Lombardi M, Ferro G, Michelassi S, Cerrai T, Pizzarelli F. [Natural history of HCV infection and risk of death in a cohort of patients on long-term hemodialysis]. G Ital Nefrol. 2006; 23(6):585-90.
32. Sekkat S, Kamal N, Benali B, Fellah H, Amazian K, Bourquia A, et al. [Prevalence of anti-HCV antibodies and seroconversion incidence in five haemodialysis units in Morocco]. Nephrol Ther. 2008; 4(2):105-10.
33. Soto-Salgado M, Perez CM, Burgos-Calderon R, Torres EA, Suarez E. Factors associated to the prevalence of antibodies to hepatitis C virus among patients receiving hemodialysis at selected dialysis centers in Puerto Rico, 2005. P R Health Sci J. 2009; 28(1):18-23.
34. Salama G, Rostaing L, Sandres K, Izopet J. Hepatitis C virus infection in French hemodialysis units: a multicenter study. J Med Virol. 2000; 61(1):44-51.
35. El-Amin HH, Osman EM, Mekki MO, Abdelraheem MB, Ismail MO, Yousif ME, et al. Hepatitis C virus infection in hemodialysis patients in Sudan: two centers' report. Saudi J Kidney Dis Transpl. 2007; 18(1):101-6.
36. Iwasaki Y, Esumi M, Hosokawa N, Yanai M, Kawano K. Occasional infection of hepatitis C virus occurring in haemodialysis units identified by serial monitoring of the virus infection. J Hosp Infect. 2000; 45(1):54-61.
37. Freitas SZ, da Cunha RV, Martins RM, Teles SA, Ibanhes ML, Motta-Castro AR. Prevalence, genotypes and risk factors associated with hepatitis C virus infection in hemodialysis patients in Campo Grande, MS, Brazil. Mem Inst Oswaldo Cruz. 2008; 103(4):405-8.
38. Jabbari A, Besharat S, Khodabakhshi B, Gorgan I. Hepatitis C in hemodialysis centers of Golestan province, northeast of Iran (2005). Hepat Mon. 2008; 8(1):61-5.
39. Ohsawa M, Kato K, Itai K, Tanno K, Fujishima Y, Konda R, et al. Standardized prevalence ratios for chronic hepatitis C virus infection among adult Japanese hemodialysis patients. J Epidemiol. 2010; 20(1):30-9.
40. Ahmetagic S, Hantalasevic L, Tihic N, Jusufovic E, Stojic V. [Hepatitis C virus infection in hemodialysis patients in General Hospital Gracanica]. Med Arh. 2006; 60(5):298-300.
41. Mahdavimazdeh M, Hosseini-Moghaddam S, Alavian S, Yahyazadeh H. Hepatitis B Infection in hemodialysis patients in Tehran province, Iran. Hepat Mon. 2009; 9(3):206-10.